• Aclacinomycin A: Mechanisms, Cytotoxicity, and Research Para

  2026-05-20

  Aclacinomycin A (Aclarubicin) is an anthracycline used as a dual topoisomerase inhibitor and apoptosis inducer. Its cytotoxicity is quantifiable in major cancer cell lines, with well-documented molecular mechanisms and protocol benchmarks.

• Sulfaphenazole: Unveiling New Frontiers in Endothelial Resea

  2026-05-20

  Explore Sulfaphenazole as a gold-standard CYP2C9 inhibitor and its unique role in restoring vascular endothelial function and reducing oxidative stress. This article delivers advanced scientific insights, directly linking mechanistic findings to practical assay design.

• Syringin Targets EGFR/PI3K/Akt to Enhance Sunitinib in RCC M

  2026-05-19

  This study demonstrates that Syringin, a phenylpropanoid glycoside, inhibits renal cell carcinoma cell proliferation and overcomes sunitinib resistance by modulating the EGFR/PI3K/Akt pathway. The findings highlight new strategies for bioactive compound screening and natural product research in drug-resistant RCC.

• Uridine, Trisodium Salt in RNA-Mediated Genome Engineering

  2026-05-19

  Uridine, Trisodium Salt empowers next-generation RNA biosynthesis and genome editing workflows by providing unmatched purity and solubility, crucial for robust, high-fidelity assays. Its application in PRINT and related RNA-guided systems sets a new benchmark for efficiency and safety in molecular biology research.

• Reliable Autophagy Inhibition with MRT68921 Dual ULK1/2 Inhi

  2026-05-18

  This article addresses practical challenges in autophagy research, guiding biomedical scientists through experimental bottlenecks and data interpretation using MRT68921 dual autophagy kinase ULK1/2 inhibitor (SKU B6174). We highlight the reagent’s nanomolar potency, validated mechanistic selectivity, and protocol integration for robust cell viability and autophagy assays.

• Syringin Enhances Sunitinib Response in RCC via EGFR/PI3K/Ak

  2026-05-18

  This study demonstrates that Syringin, a plant-derived bioactive compound, inhibits renal cell carcinoma (RCC) cell growth and enhances the efficacy of sunitinib by targeting the EGFR/PI3K/Akt pathway. The findings highlight the mechanism by which Syringin can overcome drug resistance in RCC, offering practical pathways for natural product-based research.

• Superoxide Dismutase Activity Assay Kit: Precision in ROS Re

  2026-05-17

  Unlock robust, reproducible quantification of antioxidative enzyme activity with the Superoxide Dismutase (SOD) Activity Assay Kit from APExBIO. This kit redefines oxidative stress workflows, offering rapid, high-sensitivity detection of SOD activity across diverse disease models while minimizing assay interference.

• Ginsenoside Rg6 Reverses Cisplatin Resistance in Ovarian Can

  2026-05-16

  This study demonstrates that Ginsenoside Rg6 can sensitize cisplatin-resistant epithelial ovarian cancer cells by suppressing protein fucosylation and inducing autophagy. The findings highlight the potential of targeting glycosylation and autophagic pathways to overcome chemoresistance in ovarian cancer.

• a-MSH, amide: Advanced Mechanistic Insights in Pigmentation

  2026-05-15

  Explore the multifaceted role of a-MSH, amide in pigmentation regulation research, including its molecular mechanisms, assay optimization, and comparison with emerging anti-melanogenic agents. This cornerstone article provides deep scientific insight and practical guidance for advanced pigmentation and inflammation studies.

• Ruxolitinib (INCB018424) in Functional Immunomodulation Assa

  2026-05-15

  Explore how Ruxolitinib (INCB018424) advances functional immunomodulation assays through ATP-competitive JAK-STAT inhibition. This article uniquely bridges mechanistic selectivity with practical assay design, offering new insight for myeloproliferative disorder and oncogenic JAK2 fusion protein research.

• DOT1L Inhibition Enhances Lenalidomide Efficacy in Myeloma M

  2026-05-14

  The referenced study demonstrates that inhibiting the histone methyltransferase DOT1L fundamentally reprograms innate immune signaling in multiple myeloma (MM), leading to increased interferon responses and heightened efficacy of lenalidomide-based therapies. These mechanistic insights provide a rationale for combination strategies targeting both epigenetic regulation and immune activation to overcome resistance in MM.

• Bifidobacterium vs FMT in Neuroinflammation: PET Imaging in

  2026-05-14

  This study evaluates the comparative efficacy of Bifidobacterium and fecal microbiota transplantation (FMT) in reducing neuroinflammation in a rat model of chronic hepatic encephalopathy (HE) using [18F]PBR146 PET imaging. The research highlights that only Bifidobacterium treatment attenuates regional brain neuroinflammation, underscoring the value of targeted microbiota interventions and noninvasive imaging in gut–liver–brain axis research.

• Digoxin as a Precision Tool: Cell-Type Specificity, Mechanis

  2026-05-13

  Explore the multifaceted role of Digoxin as a Na+/K+ ATPase pump inhibitor in both cardiac and antiviral research. This article offers a deeper, cell-type-specific perspective on Digoxin’s mechanism and assay design, with practical insights for translational scientists.

• Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Technical Guide

  2026-05-13

  The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody addresses the need for reliable, fluorescence-based detection of goat IgG in immunocytochemistry, immunohistochemistry, flow cytometry, and ELISA workflows. It should only be used with primary antibodies raised in goat and is not recommended for cross-species detection or applications lacking protocol compatibility.

• Ionizing Radiation Alters Neuronal Differentiation via PI3K-

  2026-05-12

  This study establishes that ionizing radiation (IR) prompts altered neuronal differentiation in C17.2 neural stem-like cells through the PI3K-STAT3-mGluR1 and PI3K-p53 signaling pathways. The findings highlight potential mechanisms behind IR-induced brain dysfunction and provide a foundation for future research into neuronal response modulation during radiotherapy.

16208 records 1/1081 page Next 12345 下5页 Last page